JPRN-UMIN000044651Completed未知
The biomechanical assessment using MR mapping for associations ulnar head morphology with wrist articular cartilage damage: A non-randomized controlled trial - The wrist MRI trial
Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus0 sites50 target enrollmentStarted: December 1, 2021Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 50years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •#malignant disease #congenital disease #Bone destruction due to the systemic disease (e.g. rheumatoid arthritis) #metabolic bone disease (e.g. osteoporosis) #The person who cannot receive an examination of MR because of implanted metal in the body, claustrophobia, and the like #The person who cannot understand the purpose and method of this study
Investigators
Similar Trials
Completed
Not Applicable
MRI assessment and patient specific biomechanical modelling of ACL deficient knees to improve ACL reconstructive surgery; a feasibility study.NL-OMON42444Academisch Medisch Centrum8
Recruiting
Not Applicable
The evalustion of fatty liver disease and post-surgical response in patients undergoing bariatric surgeryKCT0003527Gachon University Gil Medical Center75
Completed
Not Applicable
Detecting Musculoskeletal Parameters by Magnetic Resonance Imaging for Biomechanical ModelsNL-OMON39569niversiteit Maastricht30
Not yet recruiting
Phase 3
Assessment of articular disc in asymptomatic and symptomatic temporomandibular disorders with MR t2 mapping technique.CTRI/2023/08/056479Aparna S
Active, not recruiting
Phase 1
Magnetic Resonance Imaging (MRI) Assessments of the Heart and Liver Iron Load in Patients With Transfusion Induced Iron OverloadMedDRA version: 19.0Level: LLTClassification code 10028534Term: Myelodysplastic syndrome NOSSystem Organ Class: 100000004864EUCTR2016-000246-62-Outside-EU/EEAovartis53